Philip Astley-Sparke

Insider Reports History

Entity
Individual
Location
C/O Biovex Group, Inc., 34 Commerce Way, Woburn, MA
Signature
/s/ Shawn Glidden, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Astley-Sparke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Executive Chairman, Director Common Stock 1.44M $14.6M $10.18 Aug 30, 2024 Direct

Insider Reports Filed by Philip Astley-Sparke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REPL Replimune Group, Inc. Aug 30, 2024 1 $0 4 Aug 30, 2024 Executive Chairman, Director
REPL Replimune Group, Inc. May 16, 2024 1 -$245K 4 May 20, 2024 Executive Chairman, Director
REPL Replimune Group, Inc. May 16, 2023 1 -$323K 4 May 18, 2023 Chief Executive Officer, Director
REPL Replimune Group, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 Chief Executive Officer, Director
REPL Replimune Group, Inc. May 16, 2022 1 -$141K 4 May 18, 2022 Chief Executive Officer, Director
REPL Replimune Group, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 Chief Executive Officer, Director
FRBN Forbion European Acquisition Corp. Dec 9, 2021 0 $0 3 Dec 9, 2021 Director